Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127426 trials found · Page 2436 of 6372
-
Promising cancer combo trial halted early
Disease control Stopped earlyThe primary objective of the study is to estimate the antitumor efficacy of nanrilkefusp alfa in combination with pembrolizumab in selected tumors.
Phase 2 • Sponsor: SOTIO Biotech AG • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a new sedative protect newborn brains during cooling?
Symptom relief CompletedManagement of neonatal pain and sedation often includes opioid therapy. A growing body of evidence suggests long-term harm associated with neonatal opioid exposure. Providing optimal sedation while neonates are undergoing therapeutic hypothermia (TH) may be beneficial but also pr…
Phase 2 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Lupus drug trial halted early: what we know
Disease control Stopped earlyThe purpose of this study is to evaluate the efficacy and safety of telitacicept in the treatment of moderately to severely active SLE.
Phase 3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New COVID-19 vaccine candidate enters early human testing
Vaccine Completedphase I study will evaluate the safety and tolerability of GEN2-Recombinant COVID-19 Vaccine (CHO cells) in healthy people aged 18 years and older. A total of 234 subjects were enrolled, of which 126 were enrolled in the 18-59-year-old group, and were randomly assigned to receiv…
Phase 1 • Sponsor: National Vaccine and Serum Institute, China • Aim: Vaccine
Last updated Jun 27, 2026 08:11 UTC
-
Can a simple pill protect kids' kidneys? new trial aims to find out
Disease control Recruiting nowWe will conduct a 12-month, double-blind, randomized, placebo-controlled trial to assess the effects of therapy with ferric citrate (FC) on changes in intact FGF23 levels (iFGF23, primary endpoint) in 160 pediatric patients (80 in each of the two arms) aged 6-18 years of either s…
Phase 2 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New hope for low platelets: avatrombopag tested in japanese ITP patients
Disease control CompletedEvaluate the efficacy, safety, and PK of avatrombopag given for 26 weeks in Japanese adults with chronic immune thrombocytopenia (ITP).
Phase 3 • Sponsor: Sobi, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Smartphone alarms and distraction techniques could help women with bladder control problems
Disease control CompletedThis randomized controlled trial evaluated the effectiveness of bladder training supported by smartphone alarm reminders and distraction techniques in women with persistent mixed urinary incontinence who continued to experience symptoms despite completing pelvic floor muscle exer…
Sponsor: Izmir Katip Celebi University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Lung washings may hold clues to cancer recurrence
Knowledge-focused Recruiting nowThe purpose of this study is to find out if fluid rinsed from peoples' airways (bronchial washing samples) during routine surgery to remove (resect) their non-small cell lung cancer (NSCLC) tumors contains enough vesicles to do testing that may help the researchers learn more abo…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Could zapping kidney nerves tame tough blood pressure in polycystic kidney disease?
Disease control OngoingRDN-ADPKD is a prospective, randomized (1:1, central randomization), single-center, hypothesis-generating, feasibility study. The purpose of the RDN-ADPKD study is to demonstrate efficacy and document safety of renal denervation (RDN) with the Paradise System in hypertensive pati…
Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for kidney cancer: experimental drug XmAb819 enters human trials
Disease control Recruiting nowThe purpose of this study is to assess the safety and tolerability of XmAb®819 administered intravenous (IV) or subcutaneous (SC) in subjects with relapsed or refractory clear cell renal cell carcinoma and to identify the minimum safe and biologically active dose and the recommen…
Phase 1 • Sponsor: Xencor, Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New approach aims to make repeat radiation safer for cancer patients
Knowledge-focused Recruiting nowThis trial applies a uniform approach to re-irradiation for planning and diagnostic image fusion, dose summation, dose calculations, and follow up for tumor control and detailed toxicity analysis of serial Organs At Risk (OARs). Serial organs include named arteries and nerves, sp…
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Can a new classification system tailor dementia care to each person?
Knowledge-focused CompletedThe purpose of this stage is to conduct analysis and discussion through expert meetings (consultation) based on the current data of the elderly in each dementia base and Rizhao Center, as well as the weekly courses and activities of the service site (base, Rizhao), and make recom…
Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Gut health breakthrough: probiotics show promise for lupus patients
Disease control CompletedDysbiosis, or disruption of the gut microbiota, leads to the onset of autoimmunity. Increasing data suggest that the gut microbiota is changed in various murine lupus models as well as in human systemic lupus erythematosus SLE patients. Ingestion of lactobacilli, which have immun…
Phase 2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Virtual reality goggles could replace pills for procedure pain
Symptom relief Recruiting nowAs a part of the current rheumatological practice skills, epidural injections through the sacrococcygeal hiatus take part in the strategy for managing radicular diseases. This technical act is easily performed in an outpatient context since it is a brief procedure, performed unde…
Sponsor: Centre Hospitalier le Mans • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New prostate implant aims to ease bathroom struggles without pills
Symptom relief OngoingA study to evaluate the safety, performance, and effectiveness of the ProVee Urethral Expander System (Investigational Device) when used in subjects with symptomatic urinary obstruction related to benign prostatic hyperplasia (BPH).
Sponsor: ProVerum Medical • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
New mRNA flu shot enters first human tests
Vaccine CompletedThis is a Phase I, first-in-human, randomized, modified double-blind, active-controlled, dose-escalation study to assess the safety and immunogenicity of up to 3 dose levels of mRNA NA vaccines, administered as a single IM injection in healthy adults aged 18 years and older. Two …
Phase 1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jun 26, 2026 17:10 UTC
-
New drug targets Hard-to-Treat cancers with KRAS G12D mutation
Disease control Recruiting nowThis is an open-label study. This means that people in this study and clinic staff will know that people will receive ASP3082. The study aims to check how safe and well-tolerated ASP3082 is for people with advanced solid tumors that have a specific mutation called KRAS G12D. Thi…
Phase 1 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New drug targets stomach and pancreatic cancers in early trial
Disease control Recruiting nowClaudin 18.2 protein, or CLDN18.2 is a protein found on cells in the digestive system. It is also found on some tumors. Researchers are looking at ways to attack CLDN18.2 to help control tumors. ASP2138 is thought to bind to CLDN18.2 and a protein on a type of immune cell called …
Phase 1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Could SAGE-718 boost brain power in Parkinson's?
Symptom relief CompletedThe primary purpose of this study is to evaluate the effect of SAGE-718 on cognitive performance in participants with Parkinson's disease mild cognitive impairment (PD-MCI).
Phase 2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 16:18 UTC
-
Could skipping a day of antipsychotics reduce side effects without worsening symptoms?
Disease control Recruiting nowThe study wishes to examine whether "extended" antipsychotic treatment, in this case, antipsychotic treatment every other day, is as effective as daily treatment. It is also evaluating whether there may be differences in terms of side effects. Participants will be randomly assig…
Phase 4 • Sponsor: Centre for Addiction and Mental Health • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC